Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine

PHASE2

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped Terminated early due to concerns from the NIH DSMB regarding the rate of recruitment and the resulting inability to accomplish the initially approved study aims

Conditions

Adolescent Suicide
Adolescent Depression

Interventions

DRUG: Ketamine Infusion
DRUG: Midazolam Infusion

Sponsor

Yale University

Collaborators

[object Object]